Math 'Genius' Maryam Mirzakhani Dies, Aged 40

Agencies
July 16, 2017

Washington, Jul 16: Maryam Mirzakhani, an Iranian-born mathematician who was the first woman to win the coveted Fields Medal, has died in a US hospital after a battle with cancer. She was 40.

Maryam

Mirzakhani' friend Firouz Naderi announced her death on Saturday on Instagram, and her relatives confirmed the death to the Mehr agency in Iran.

"A light was turned off today. It breaks my heart ..... gone far too soon," wrote Naderi, a former director of Solar Systems Exploration at NASA.

"A genius? Yes. But also a daughter, a mother and a wife," he added in a subsequent post.

Mirzakhani, a professor at Stanford University in California, died after the cancer she had been battling for four years spread to her bone marrow, Iranian media said.

In 2014 Mirzakhani won the Fields Medal, the equivalent of the Nobel Prize for Mathematics, which is awarded by the International Congress of Mathematicians.

The award recognized her sophisticated and highly original contributions to the fields of geometry and dynamical systems, particularly in understanding the symmetry of curved surfaces such as spheres.

Born in 1977 and raised in Tehran, Mirzakhani initially dreamed of becoming a writer, but by the time she started high school her affinity for solving mathematical problems and working on proofs had shifted her sights.

"It is fun -- it's like solving a puzzle or connecting the dots in a detective case," she said when she won the Fields Medal.

"I felt that this was something I could do, and I wanted to pursue this path."

Mirzakhani said she enjoyed pure mathematics because of the elegance and longevity of the questions she studies.

"It is like being lost in a jungle and trying to use all the knowledge that you can gather to come up with some new tricks, and with some luck you might find a way out," she added.

In 2008 she became a professor of mathematics at Stanford. She is survived by her husband and young daughter.

- "Great sorrow" -

In Iran, President Hassan Rouhani said that Mirzakhani's "doleful passing" has caused "great sorrow," state media reported.

Rouhani praised the "unprecedented brilliance of this creative scientist and modest human being, who made Iran's name resonate in the world's scientific forums, (and) was a turning point in showing the great will of Iranian women and young people on the path towards reaching the peaks of glory...in various international arenas."

Separately on Instagram, Iranian Foreign Minister Mohammad Javad Zarif said that Mirzakhani's death is a cause for grief for all Iranians.

Mirzakhani became known on the international mathematics scene as a teenager, winning gold medals at both the 1994 and 1995 International Math Olympiads -- and finished with a perfect score in the latter competition.

She went on to win the 2009 Blumenthal Award for the Advancement of Research in Pure Mathematics, and the 2013 Satter Prize of the American Mathematical Society.

Mirzakhani studied mathematics in Iran and earned a PhD degree from Harvard in 2004. She then taught at Princeton University before moving to Stanford in 2008.

The Fields Medal, which she won in 2014, is given out every four years, often to multiple winners aged 40 or younger.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
March 25,2020

Moscow, Mar 25: An earthquake measuring 7.5 on the Richter scale struck off Russia's Kuril Islands on Wednesday, the United States Geological Survey (USGS) said.

The magnitude of the quake, which occurred at 2:49 am (UTC), was registered at a depth of 56.7 kilometres, about 219 kilometres southeast of the Russian town of Severo-Kuril'sk, the USGS said.

There were no immediate reports of casualties or damage to the property as a result of the quake.
Further details are awaited.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 25,2020

Beijing, Mar 25: Around 5,000 people have signed up for the phase I clinical trial of recombinant novel coronavirus vaccine in Chinese city Wuhan where the virus first emerged late last year.

The recruitment for participants ended this week with nearly 5,000 volunteers signing up for the trial, state-run Beijing News reported on Wednesday.

A single-centre, open and dose-escalation phase I clinical trial for recombinant novel coronavirus vaccine (adenoviral vector) will be tested in healthy adults aged between 18 and 60 years, according to the ChiCTR (China Clinical Trial Register).

The trial, led by experts from the Academy of Military Medical Sciences, gained its approval on March 16 and the research is expected to last half a year.

Requiring at least 108 participants, the trial will be conducted in Wuhan, capital of Hubei province, the region worst-affected by the virus in the country, state-run China Daily reported.

Participants will experience 14-day quarantine restrictions after being vaccinated and their health condition will be recorded every day.

Chinese scientists are hastening the development of COVID-19 vaccines through five approaches --- inactivated vaccines, genetic engineering subunit vaccines, adenovirus vector vaccines, nucleic acid vaccines and vaccines using attenuated influenza virus as vectors.

So far, most teams are expected to complete preclinical research in April and some are moving forward faster, Wang Junzhi, an academician with the Chinese Academy of Engineering said.

Wang noted that research and development of COVID-19 vaccines in China is not slower than foreign counterparts and has been carried out in a scientific, standardised and orderly way.

China has stepped up the process to finalise vaccines to counter COVID-19 after Kaiser Permanente research facility in Seattle and Washington stole the march and began human trials.

China lifted tough restrictions on the Hubei province on Wednesday after a months-long lockdown as the country reported no new domestic cases.

But there were another 47 imported infections from overseas, the National Health Commission said. In total, 474 imported infections have been diagnosed in China -- mostly Chinese nationals returning home.

Comments

Y UDAYA CHANDAR
 - 
Monday, 13 Apr 2020

Dear Sir,

 

I am 77 but a very healthy person with remarkable immunity. I contracted Malaria fever in 1994 because of mosquito biting and I have not been sick anytime there after, not even for ordinary fever in the last 26 years.

 

I am sure you would like to conduct the trials on persons of varying criteria. I am sure you don't want to carry out the trials on perfectly healthy young individuals only. 

 

I am certain that  you want to try the vaccine on a 'common man' from 'general public.' I am ready for the trial and you can take me. I will be delighted. 

 

If you are not handling this matter kindly forward this mail to the correct agency.

 

I look forward to hearing from you.

 

Best regards.

 

If you are not moving forward, you are really moving backward.

Y Udaya Chandar

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
March 27,2020

London, Mar 27:  British Prime Minister Boris Johnson said Friday he has tested positive for the new coronavirus, but remains in charge of the U.K.'s response to the outbreak.

Johnson's office said he was tested on the advice of the chief medical officer after showing mild symptoms.

It said Johnson is self-isolating at his 10 Downing St. residence and continuing to lead the country's response to COVID-19.

In a video message, Johnson said he had a temperature and a persistent cough.

Over the last 24 hours I have developed mild symptoms and tested positive for coronavirus.

I am now self-isolating, but I will continue to lead the government’s response via video-conference as we fight this virus.

Together we will beat this. #StayHomeSaveLives pic.twitter.com/9Te6aFP0Ri

— Boris Johnson #StayHomeSaveLives (@BorisJohnson) March 27, 2020
"Be in no doubt that I can continue, thanks to the wizardry of modern technology, to communicate with all my top team, to lead the national fightback against coronavirus."

Earlier this week Britain’s Prince Charles announced that he had tested positive for the virus.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.